Jabil Inc. (JBL) Q3 2025 Filing Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended May 31, 2025, and the nine months ended May 31, 2025. Jabil Inc. is a leading provider of worldwide manufacturing services and solutions. Effective September 1, 2024, the company reorganized its reporting into three segments: Regulated Industries, Intelligent Infrastructure, and Connected Living and Digital Commerce.
Key Financial Metrics
| Metric (in millions) | Q3 2025 | Q3 2024 | 9M 2025 | 9M 2024 |
|---|---|---|---|---|
| Net Revenue | $7,828 | $6,765 | $21,550 | $21,919 |
| Gross Profit | $681 | $608 | $1,863 | $2,013 |
| Gross Margin | 8.7% | 9.0% | 8.6% | 9.2% |
| Operating Income | $403 | $261 | $845 | $1,695 |
| Net Income (GAAP) | $222 | $129 | $439 | $1,250 |
| Diluted EPS (GAAP) | $2.03 | $1.06 | $3.94 | $9.86 |
| Operating Cash Flow (9M) | $1,052 (2025) vs $1,181 (2024) | |||
| Cash & Equivalents | $1,523 (as of May 31, 2025) | |||
| Total Debt | $2,884 (as of May 31, 2025) |
Material Changes vs. Prior Period
- Revenue Growth: Q3 2025 revenue increased 15.7% year-over-year, driven primarily by a 51% surge in the Intelligent Infrastructure segment (cloud/data center and capital equipment). This offset a 7% decline in the Connected Living segment.
- Profitability: Operating income rose 54% in Q3 2025 compared to Q3 2024. However, the nine-month operating income decreased 50% due to the absence of the $944 million pre-tax gain from the Mobility Business divestiture recorded in the prior year.
- Restructuring: Restructuring charges decreased to $16 million in Q3 2025 from $55 million in Q3 2024, reflecting the winding down of the 2024 plan and the early stages of the 2025 plan.
- Divestiture Gains: A $45 million pre-tax gain was recognized in Q3 2025 from post-closing adjustments related to the prior year's Mobility Business sale.
- Loss on Securities: A $46 million loss on securities (impairment of Preferred Stock) impacted Q3 and 9M 2025 results, with no comparable loss in the prior year.
Guidance, Outlook, and Risks
- Restructuring Plan: The company expects to recognize approximately $200 million in pre-tax restructuring costs for fiscal year 2025, with net cash expenditures of $100–$130 million payable over FY2025 and FY2026.
- Capital Expenditures: Net capital expenditures for FY2025 are anticipated to be in the range of 1.5% to 2.0% of net revenue.
- Share Repurchases: Under the 2025 Share Repurchase Program, the company has repurchased $975 million of stock, with $25 million remaining authorized as of May 31, 2025.
- Tariff Risks: Management notes that U.S. tariffs implemented in February 2025 and retaliatory measures may impact end-customer demand. The company expects to pass these costs to customers but warns that failure to do so could adversely affect operating results.
- Acquisitions: Completed acquisitions of Pharmaceutics International, Inc. (Pii) and Mikros Technologies LLC are expected to enhance Regulated Industries and Intelligent Infrastructure offerings, respectively. A binding agreement for Rebound Technologies was signed in June 2025.
Investor Verification Checklist
- Segment Mix: Verify the sustainability of the 51% revenue growth in Intelligent Infrastructure and its impact on overall gross margins.
- Restructuring Execution: Monitor the timing and cash impact of the $200 million 2025 restructuring plan.
- Tariff Exposure: Assess the company's ability to pass on tariff costs to customers without losing market share.
- One-Time Items: Adjust analysis for the $46 million securities impairment and the $45 million divestiture gain to understand core operating performance.
- Liquidity: Review the utilization of the new $3.2 billion revolving credit facility entered into in June 2025.